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Background:  The  need  to map  pathogenic  bacteria  from  oral  lesions  of  patients  with  human  immuno-
deﬁciency  virus  and  acquired  immunodeﬁciency  syndrome  (HIV/AIDS)  remains  crucial  to  estimate  the
potential  risk  of  localized  and  systemic  diseases.
Objective: The  aim of this  study  was  to  determine  the baseline  burden  and  antibiotic  susceptibility  of
pathogenic  bacteria  recovered  from  oral  lesions  of  patients  with  HIV/AIDS  in  South-Western  Uganda.
Methods: World  Health  Organization’s  aseptic  criteria  were  adopted  in oral  examination,  sample  (605)
collection,  pathogenic  bacteria  isolation,  and sensitivity  testing.  The  included  patients  with  HIV/AIDS  had
persistent  oral  lesions,  and  they  received  antibiotic  treatment.  The  study  was  ethically  approved  by  the
institutional  and national  boards.
Results: Pathogenic  bacteria  (31%  Streptococcus  mutans,  16.4%  Proteus  mirabilis,  11.8%  nonhemolytic  Strep-
tococcus  species,  11.3%  Staphylococcus  aureus,  9.5%  Branhamella  catarrhalis,  8.6%  Pseudomonas  aeruginosa,
8.1%  Klebsiella  pneumoniae,  6.8%  Escherichia  coli,  and 5.5%  Streptococcus  pyogenes)  prevalence  varied  sig-
niﬁcantly  (p  < 0.05)  with  participating  districts,  and  this  may  indicate  that patients  are  at  an  increased
risk  of  systemic  infection  and  antibiotic  resistance.  Females  were  more  in  number  than  males,  and  31–50
years  were  the  most  predominant  age groups.  The  variation  of oral pathogenic  bacteria  represents  the
distribution  of  two  ethnics  made  of  ﬁve  tribes.  Gentamycin  was the  most  effective  antibiotic  against
all  isolates.  Relative  resistance  to oral  antibiotics  and sensitivity  to  ciproﬂoxacin/cefaclor  were  bacteria-
dependent.  An  effective  treatment  plan  for  persistent  oral  lesions  should be  against  pathogenic  bacteria
and  fungi.
Conclusions:  An  observed  wide  array  of  potentially  pathogenic  bacteria  in the  oral  cavity  of  patients  with
HIV/AIDS  poses  a real problem  in the  world  of  antimicrobial  resistance,  and  this  clearly  provides  a  higher
risk  of  systemic  infectious  diseases  in these  population  with  HIV/AIDS.
©  2015  Japanese  Stomatological  Society.  Published  by Elsevier  Ltd.  All  rights  reserved.. Introduction
The oral microbial population predominated by pathogenic
acteria may  relatively be stable in health, but any adverse
hanges by surgery and underlying defects in the innate or
peciﬁc immune systems predispose the mouth to infections
∗ Corresponding author at: The Special Pathogens Research Network Limited,
ushenyi,  Kampala, Uganda. Tel.: +256 782101486; fax: +256 703129679.
E-mail  addresses: drezera@spparenet.us, ageuezera@yahoo.com (E. Agwu).
ttp://dx.doi.org/10.1016/S1348-8643(15)00018-X
348-8643/© 2015 Japanese Stomatological Society. Published by Elsevier Ltd. All rights r[1,2]. Pathogenic bacteria frequently detected from different
oral conditions may  include Fusobacterium necrophorum, Pre-
votella intermedia, cloxacillin-sensitive and erythromycin-sensitive
Staphylococcus aureus, Treponema palladium and other species,
Mycobacterium tuberculosis, alpha-hemolytic Streptococci, Strepto-
cocci aureus, and Gram-negative anaerobic organisms [3–5].
Deﬁning the burden of oral pathogenic bacterial infections is dif-
ﬁcult because apart from taking part in primary oral mucosal
infections, they are frequently associated with secondary systemic
disease, induced by bacteremia, injury due to oral microorganisms,
and pathogenic bacterial toxins [6–8].
eserved.
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The prevalence of oral microbial (including pathogenic bacte-
ia) lesions among patients with human immunodeﬁciency virus
nd acquired immunodeﬁciency syndrome (HIV/AIDS) shows a
egional and geographical variation. The global report of oral
icrobial (including pathogenic bacteria) disease prevalence in
IV/AIDS disease was 40–50% [9], and other reports from dif-
erent regions of the world include 13–45% from India [10],
3–79% from Nigeria [11], 34–74.9% from USA [12], and an aver-
ge of 73% from Uganda [12]. The condition was slightly similar
5.5–57%) in a Brazilian report on patients with non-HIV having
ther infectious diseases [13]. Persistent oral microbial (includ-
ng pathogenic bacteria) lesions in patients who are HIV-positive
ay be explained by the concept of idiosyncratic reactions or
llnesses [14], and they are deﬁned as adverse reactions of the
ody to foreign substances including food and drugs, which occur
hrough unknown mechanisms and with a poorly understood cause
nd effect relationship of the variables. Such variables may  be
ue to host-related (malnutrition, age, gender, pregnancy, or obe-
ity), environmental-related (smoking, alcohol consumption, and
nfection), and drug-related (daily dose, metabolic proﬁle, drug
nteraction, and cross-sensitization) variables [14–16].
.1.  Justiﬁcation
Despite the high prevalence of recurrent oral conditions,
tiopathogenesis remains elusive, incompletely understood, and
arrants research attention. There are many reports about oral
esion prevalence, but little is known about reoccurring lesions
mong patients with HIV/AIDS under routine drugs. United States
f America and Nigeria reported 15.2% and 26% rebound of
ral lesions, respectively, in HIV/AIDS disease [12,17]. A previ-
us report [18] suggesting that S. aureus, hemolytic Streptococci,
nterococci, Escherichia coli, Klebsiella, Pseudomonas, and other
athogenic bacteria play a role in the pathogenesis and persis-
ence of complicated oral fungal lesions needs to be conﬁrmed
nd/or duplicated in HIV/AIDS endemic in South-Western Uganda.
orthy of note and replication is the report that pathogenic
acteria are involved in the microbial, immunological, and
onmicrobial factors (trauma, drugs, hematinic deﬁciency, sodium-
auryl-sulfate-containing toothpaste, tobacco, and stress) leading
o the persistence of oral lesion among patients on routine drugs in
esource-limited settings [19].
Understanding the microbial details of recurrent oral disease
onditions, especially in the immunocompromised patients, may
trengthen the capacity to mount a more focused and coor-
inated surveillance for an effective intervention. Furthermore,
he association of oral pathogenic bacteria with secondary sys-
emic disease and the conﬁrmation that the oral cavity may
e a potential source or reservoir of pathogenic species justify
he need to characterize as well as determine the susceptibil-
ty status of the pathogenic bacterial isolates of persistent oral
esions of patients with HIV infection and AIDS [6,20]. A clear
utline of the susceptibility pattern of pathogenic bacterial iso-
ates to antibiotics is paramount to the design and implementation
f an effective intervention during the rebound of oral lesions
21,22].
.2. Signiﬁcance
A  survey of oral pathogenic bacteria carriage and an outline of
ts susceptibility status would have a profound epidemiological
nd public health signiﬁcance in relation to the plan for effec-
ive interventions. The management of oral mucosal disease in
esource-poor settings currently focuses on oral mycosis [1,23],
ith little attention paid to the possible involvement of pathogenicnational 12 (2015) 59–66
bacteria  even in classical cases of treatment failure of oral lesions
among patients with HIV/AIDS.
1.3. Objectives
The objectives of this study were to determine the baseline bur-
den of pathogenic bacteria recovered from oral lesions of patients
with HIV/AIDS in South-Western Uganda, and to outline the suscep-
tibility pattern of isolates to commonly used antibacterial agents
with the ultimate goal of providing a database for the future man-
agement of pathogenic oral and systemic bacterial diseases.
2.  Methods
A total of 605 known patients with HIV/AIDS, recruited for this
study, were clinically diagnosed with oral lesions by trained and
calibrated oral clinicians, while attending clinics at three TASO
(The AIDS Support Organization) Centers in Masaka, Rukunguri,
and Mbarara districts of Uganda. Mbarara district TASO centers
included Mbarara Metropolitan Center and Mbarara-controlled
outreach centers located in Mitooma, Katungu, and Kigarama vil-
lages.
2.1. Inclusion criteria
Known  patients with HIV/AIDS who were clinically diagnosed
with oral lesions by trained and calibrated oral clinicians using
the World Health Organization’s established clinical criteria for
HIV-associated oral lesions used in our former report [1] and who
complained of oral lesions’ persistence despite receiving routine
oral co-trimoxazole, clotrimazole, nystatin, and ﬂuconazole were
included.
2.2. Ethical issues
Informed  consent was  sought and obtained from the Uganda
National Council for Science and Technology, the Kampala Interna-
tional University Western Campus Research and Ethics Committee,
and TASO at both local and national levels, and from TASO clients
(patients) through their informed consent. Letters were written
in English, translated, and interpreted into local languages spo-
ken at the various TASO centers. TASO clients signed or printed
their thumb to show the approval for sample collection. Where the
clients could not read or write in English or local languages, the
letter containing the beneﬁts of the research study was read and
interpreted to the clients before thumb-printing after understand-
ing the read text.
2.3.  Sample size
The  number of oral samples (n = 605) obtained from oral lesions
of patients with HIV/AIDS was  guided by the upper limit required
to give a 95% level of conﬁdence at an expected prevalence of
about 55% [24], using the precise prevalence formula: sample size
(N) = Z2P(100 − P)/D2 (Epi-info version 3.2 database, 1995), where
Z is a constant given as (1.96), P is the expected prevalence (55%),
and D is the acceptable error (5%).
2.4. Sample collection and analysis
A disposable wooden tongue depressor was used to retract
the cheeks, while sterile swab sticks (Evepon®, Anambra, Nigeria)
were used to aseptically collect samples from the oral lesions
of the patients. After collection, the samples were immediately
taken to the Laboratory Unit of the Microbiology Department, Kam-
pala International University, Western Campus (KIU-WC), Ishaka,
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Table  1
Demographic characteristics of 605 participants from Mbarara, Rukungiri, and Masaka.
Age (years) Mbarara Rukungiri Masaka
F = 253 M = 58 F = 109 M = 43 F = 107 M = 35
1–10 3 (1.2) 0 (0.0) 1 (0.9) 0 (0.0) 1 (1.0) 0 (0.0)
11–20 4 (1.6) 1 (1.7) 1 (0.9) 0 (0.0) 4 (3.7) 1 (2.9)
21–30 29 (11.5) 7 (12.1) 15 (13.8) 7 (16.3) 18 (16.8) (14.3)
31–40 109 (43.0) 32 (55.2) 42 (38.5) 16 (37.2) 47 (44.0) 5 (42.8)
41–50 78 (30.8) 14 (24.1) 37 (34.0) 12 (27.9) 24 (22.4) 0 (28.5)
51–60 28 (11.1) 4 (6.9) 8 (7.3) 5 (11.6) 10 (9.3) 3 (8.6)
>60 2 (0.8) 0 (0.0) 5 (4.6) 3 (7.0) 3 (2.8) 1 (2.9)
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and highly active antiretroviral therapy (HAART) from the three
districts sampled. Patients whose oral lesions were swabbed for
pathogenic bacterial isolation were those who  complained of treat-
ment failure, and have oral lesions despite being placed on routine
Table 2
A  summary of the recurrent oral conditions among patients with HIV infection and
AIDs receiving routine cotrimoxazole, nystatine, and HAART.
Number (%) positive recurrent oral conditions n = 605
Pseudomembranous candidiasis 166 (27.4)
Erythematous candidiasis 27 (4.5)
Angular chelitis 12 (2.0)
Linear gingival erythematous banding 6 (1.0)
Pseudomembranous and erythematous candidiasis 171 (28.2)
Pseudomembranous candidiasis and angular chelitis 78 (12.9)
Erythematous candidiasis and angular chelitis 9 (1.5)
Kaposi sarcoma 19 (3.1), females; M,  males.
ushenyi, Uganda, for analysis. In cases where there were delays
n getting the samples to the laboratory, the samples were trans-
orted in a phosphate-buffered physiological saline in a vaccine
arrier [25], and all media used were prepared under aseptic con-
itions and with stringent adherence to media performance control
riteria in line with manufacturer’s instructions (Mast Diagnos-
ics, Mumbai, India). Brieﬂy, an overnight broth culture of samples
noculated on a brain–heart infusion (BHI) broth was  incubated for
8–24 h (overnight) at 37 ◦C, under reduced oxygen tension in an
nclosed jar with a glowing candle. The candle glows till extinction
o create an atmosphere containing reduced oxygen and increased
arbon dioxide to support the growth of fastidious aero-tolerant
ral pathogenic bacteria species. Overnight broth suspensions were
lated out on a BHI agar supplemented with 5% sheep blood to get a
lood agar, which was then incubated overnight on reduced oxygen
ension as mentioned above [26–28].
Inoculation of samples onto prepared media was  done asepti-
ally, and after an 18–48-h incubation, suspect pathogenic bacteria
pecies of clinical signiﬁcance (>25 discrete colonies per cul-
ure plate) were picked for further identiﬁcation. Thus, discrete
athogenic bacteria colonies appearing on the pool of inoculum
nd in the lines of striking were picked for further identiﬁcation,
hile mixed growth was ﬁrst puriﬁed to get discrete colonies
efore being taken for further identiﬁcation. Standard guidelines
ere adopted during the identiﬁcation of pathogenic bacte-
ial isolates [29,30]. Brieﬂy, some tests performed that assisted
n pathogenic bacterial identiﬁcation using standard guidelines
ncluded pathogenic bacterial assimilation of selected sugars such
s glucose, lactose, rafﬁnose, sucrose, mannitol, dextrose, and malt-
se; pathogenic bacterial production of enzymes such as catalase,
oagulase, lipase, DNAse, and esterase enzymes; and pathogenic
acterial hemolytic characteristics tested on blood agar. Other tests
onducted included optochin and bacitracin susceptibility, oxidase,
ethyl red, Voges–Proskauer, citrate utilization, urease hydroly-
is, hydrogen sulﬁde production, indole and motility tests, starch
ydrolysis, nitrate reduction, and bile esculin test.
.5.  Antibacterial susceptibility testing
This was done in line with the modiﬁed Clinical Laboratory Stan-
ards Institute (CLSI) guidelines for conducting the Kirby–Bauer
isk diffusion susceptibility testing of antibiotics [31]. Antibiotic
election was done in line with previously reported standard
ethods [32,33]. Brieﬂy, standard suspensions (0.5 McFarland)
f identiﬁed pathogenic bacteria colonies were inoculated onto
repared plates of Mueller–Hinton agar using sterile swab sticks.
ommercially available disks (Mast Group, India; Oxoid, UK) with
isk content as shown in Tables 4–6 were aseptically placed at
he top of the inoculated media. To ensure noninterference of
ones of clearance and ease of interpretation, ﬁve disks were used
er plate. After incubation at 35 ◦C for 18–24 h, zone sizes weremeasured  and interpreted as “sensitive”, “intermediate”, and
“resistant” using CLSI guidelines [32].
2.6. Statistical analysis
The  randomized block design (RBD) (  ˛ = 0.05 or 99.95% level of
conﬁdence), summarized as (the total sum of squares (SST) = sum
of squares due to different effects (SSD) + error sum of effects
(SSE)) [34], for one observation per treatment was used to test for
the relationship between oral pathogenic bacteria population and
oral lesions among TASO clients with HIV infection. Susceptibility
results were also tested with RBD or completely randomized design
(CRD).
3. Results
3.1. Demographic characteristics of participants
Table 1 shows the demographic characteristics of participants in
three (Mbarara, Rukungiri, and Masaka) districts of Uganda. Overall,
there were more females than males in the entire three districts
studied. Majority of the participants fall within the age groups of
31–50 years, while participants at extremes of ages (<10 years and
>60 years of age) were least in the number of recruited participants.
The total number of participants was  highest in Mbarara followed
by those from Rukungiri and Masaka districts, respectively.
3.2.  Recurrent oral conditions of participants
Table 2 shows the recurrent oral conditions of patients with
HIV infection and AIDS receiving routine co-trimoxazole, nystatin,Recurrent aphthous ulceration 12 (2.0)
Xerostomia 50 (8.3)
Unclassiﬁed oral conditions 55 (9.1)
n, number sampled.
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Table  3
Percentage prevalence of pathogenic bacteria isolated from patients with HIV infection and AIDS in the three districts (Masaka, Rukungiri, and Mbarara) surveyed.
Organisms n = 605
Number (%) prevalence
Masaka Rukungiri Mbarara
n  = 142 n = 152 n = 311
Streptococcus mutans 45 (31.7) 34 (22.4) 96 (30.9)
Streptococcus  pyogenes 7 (4.9) 0 (0.0) 17 (5.5)
Staphylococcus  aureus 16 (11.3) 11 (7.2) 35 (11.3)
Non-hemolytic  Streptococcus 0 (0.0) 18 (11.8) 14 (4.5)
Pseudomonas  aeruginosa 2 (1.4) 13 (8.6) 0 (0.0)
Klebsiella  pneumoniae 12 (8.5) 8 (5.3) 13 (4.2)
Proteus  mirabilis 4  (2.8) 25  (16.4) 0  (0.0)
Escherichia  coli 10  (7.0) 5  (3.3) 19 (6.1)
Bacillus  subtilis 4 (2.8) 2 (1.3) 0 (0.0)
Bacillus  cereus 2 (1.4) 1 (0.7) 0 (0.0)
Brahmella  catarrhalis 14 (9.9) 9 (5.9) 14 (4.5)
Diphtheroids  7 (4.9) 0 (0.0) 0 (0.0)
Total  number of pathogenic bacterial isolates 123 (86.6) 126 (82.9) 208 (66.9)
No  pathogenic bacterial growth 19 (13.4) 26 (17.1) 103 (33.1)
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E, total number sampled. Using RBD and FLSD, there were signiﬁcant differences
ompared within districts (a) and between districts (b).
ntiviral, antifungal, and antipathogenic bacterial drugs (HAART,
ystatine, and co-trimoxazole, respectively) during their previous
isits to the hospital. Xerostomia was included because it was
mong the oral conditions seen among patients who came for
he second time. Unclassiﬁed oral conditions are those lesions in
hich the attending clinicians could not make deﬁnite decisions
bout their clinical diagnosis but they wrote oral lesions diagnosed.
seudomembranous and erythematous oral lesions were the most
ommon lesions seen among the patients.
.3. Pathogenic bacteria distribution by districts surveyed
The  result in Table 3 shows that out of 605 samples collected
nd analyzed, 142 were from Masaka, 152 from Rukungiri, and 311
rom Mbarara region. Pathogenic bacteria prevalence was  highest
t 123 (86.6%) in Masaka followed by 126 (82.9%) in Rukungiri and
08 (66.9%) in Mbarara region. The most predominant bacterium
n the districts surveyed was 96 (30.9%) Streptococcus mutans from
barara, followed by 25 (16.4%) Proteus mirabilis from Rukungiri,
5 (11.3%) S. aureus and 18 (11.8%) nonhemolytic Streptococcus
pecies each from Mbarara and Rukungiri districts, respectively,
nd 14 (9.5%) Branhamella catarrhalis isolated from Masaka.Other  pathogenic bacteria isolated in the descending order
f their percentage distribution include 13 (8.6%) Pseudomonas
eruginosa from Rukungiri district, 12 (8.5%) from Masaka dis-
rict, 10 (7.0%) E. coli from Masaka district, 17 (5.5%) S. pyogenes
able 4
usceptibility pattern of pathogenic bacterial isolates from Masaka district.
Organisms Antibiotics and number (%) positive
Met  (10 g) Cip (5 g) Clox (5 g) Ox (1 
S. mutans (n = 45) 8 (17.8) 22 (48.9) 0 (0.0) 5 (11.1)
S.  pyogenes (n = 7) 3 (42.9) 7 (100.0) 2 (28.2) 3 (42.9)
S.  aureus (n = 16) 3 (18.8) 12 (80.0) 5 (31.3) 3 (18.8)
P.  aeruginosa (n = 2) 0 (0.0) 2 (100.0) 0 (0.0) 0 (0.0) 
K  pneumo (n = 12) 5 (41.7) 4 (33.3) 4 (33.3) 2 (16.7)
P.  mirab (n = 4) 0 (0.0) 4 (100.0) 0 (0.0) 0 (0.0) 
E.  coli (n = 10) 3 (30.0) 7 (70.0) 0 (0.0) 0 (0.0) 
B.  subtilis (n = 4) 2 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 
B.  cereus (n = 2) 0 (0.0) 0 (0.0) 2 (100.0) 2 (100.0
B.  catars (n = 14) 6 (42.9) 8 (57.1) 3 (21.4) 6 (42.9)
Diphth  (n = 7) 2 (28.6) 4 (57.1) 0 (0.0) 3 (42.9)
ey: Met, Methicillin; Cip, Ciproﬂoxacin; Clox, Cloxacillin; Ox, Oxacillin; Tet, Tetracyclin
utans; S. pyogenes, Streptococcus pyogenes; S. aureus, Staphylococcus aureus; P. aerug, Pse
.  coli, Escherichia coli; B. subtilis, Bacillus subtilis; B. cereus, Bacillus cereus; B. catars, Brahm the prevalence of different pathogenic bacterial strains in the oral mucosa was
from  Mbarara, seven (4.9%) diphtheroids from Masaka district, and
four (2.8%) Bacillus subtilis from Masaka district. The prevalence
of pathogenic bacteria strains in the oral mucosa was  signiﬁcantly
dependent on the district where pathogenic bacteria were isolated.
3.4. Susceptibility status of pathogenic bacteria isolates from
Masaka  patients
Table  4 shows 30 (66.7%) out of 45 strains of S. mutans; 30 (66.7%)
were susceptible to gentamycin and 22 (48.9%) were susceptible to
ciproﬂoxacin. All seven (100%) strains of S. pyogenes were suscep-
tible to ciproﬂoxacin and six (85.7%) strains were susceptible to
gentamycin. Twelve (80%) strains of S. aureus were susceptible to
ciproﬂoxacin, 11 (68.8%) strains were susceptible to gentamycin,
and eight (50.0%) to penicillin G. All two  (100%) strains of P.
aeruginosa were uniformly susceptible to ciproﬂoxacin and gen-
tamycin, respectively. Eleven (91.7%) out of 12 strains of Klebsiella
pneumoniae were susceptible to gentamycin, and six (50%) were
susceptible to amoxicillin and penicillin G. All four (100%) strains
of P. mirabilis were susceptible to both ciproﬂoxacin and gen-
tamycin. Generally, it can be seen from the narrative above that the
quinolones and aminoglycosides appear to be very effective against
predominant pathogenic bacterial isolates. Antibacterial suscep-
tibilities were signiﬁcantly dependent on the type of pathogenic
bacteria isolated and the type of antibiotics used.
g) Tet (10 g) Gen (10 g) Amx  (25 g) PenG (10 units)
 7 (15.6) 30 (66.7) 7 (15.6) 14 (31.1)
 0 (0.0) 6 (85.7) 2 (28.2) 2 (28.2)
 4 (25.0) 11 (68.8) 7 (43.8) 8 (50.0)
0 (0.0) 2 (100.0) 0 (0.0) 0 (0.0)
 4 (33.3) 11 (91.7) 6 (50.0) 6 (50.0)
0 (0.0) 4 (100.0) 2 (50.0) 2 (50.0)
3 (30.0) 10 (100.0) 3 (30.0) 6 (60.0)
0 (0.0) 4 (100.0) 4 (100.0) 2 (50.0)
) 2 (100.0) 0 (0.0) 2 (100.0) 0 (0.0)
 6 (42.9) 7 (50.0) 5 (35.4) 4 (28.6)
 0 (0.0) 6 (85.7) 0 (0.0) 2 (28.6)
e; Gent, Gentamycin; Amx, Amoxycillin; Pen G, Penicillin G; S. mut, Streptococcus
udomonas aeruginosa; K. pneumo, Klebsiella pneumoniae; P. mirab, Proteus mirabilis;
alella catarrhalis; Diphth, Diphtheroids. n = 123 and p < 0.05.
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Table  5
Susceptibility pattern of isolates from Mbarara districts.
Organisms n = 208
Antibiotics and number (%) positive
Met  (100 g) Cip (5 g) Clx (300 g) Ox (1 g) Ccl (30 g) Gent (100 g) Ery (5 g) Amx  (25 g)
K. pneumo (n = 13) 0 (0.0) 9 (69.2) 6 (46.2) 0 (0.0) 6 (46.2) 12 (92.3) 0 (0.0) 5 (38.5)
S.  mutans (n = 96) 26 (27.1) 80 (83.3) 60 (62.5) 25 (26.0) 30 (31.3) 96 (100.0) 11 (11.5) 5 (5.2)
NH  strept (n = 14) 0 (0.0) 9  (64.3) 14  (100.0) 0  (0.0) 7  (50.0) 13  (92.8) 13 (92.8) 0 (0.0)
S.  pyogenes (n = 17) 3 (17.6) 10 (58.8) 6 (35.5) 0 (0.0) 10 (58.8) 17 (100.0) 6 (35.2) 0 (0.0)
E.  coli (n = 19) 0 (0.0) 12 (63.2) 10 (52.6) 0 (0.0) 13 (69.4) 18 (94.7) 0 (0.0) 9 (47.5)
S.  aureus (n = 35) 0 (0.0) 15 (42.9) 0 (0.0) 0 (0.0) 20 (57.1) 33 (94.3) 16 (45.7) 0 (0.0)
B.  catars (n = 14) 0 (0.0) 7 (50.0) 0 (0.0) 0 (0.0) 10 (71.4) 13 (92.9) 13 (92.9) 2 (14.3)
Key: Met, Methicillin; Cip, Ciproﬂoxacin; Clx, Cephalexin; Ox, Oxacillin; CCL, Cefaclor; Gent, Gentamycin; Amx, Amoxycillin; Ery, Erythromycin; S. mutans, Streptococcus
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BD  and FLSD, there was  a signiﬁcant difference in the effect of the antibiotics when
ercentage-sensitive.
.5. Susceptibility status of pathogenic bacteria from Mbarara
atients
Table  5 shows the summary of susceptibility results of isolates
btained from Mbarara district against selected representative
ntimicrobial agents. Out of the 13 strains of K. pneumoniae iso-
ated, 12 (92.3%) were susceptible to gentamycin, nine (69.2%)
ere susceptible to ciproﬂoxacin, and all 13 (100%) were resis-
ant to methicillin, oxacillin, and erythromycin, respectively. All
he 96 (100%) strains of S. mutans were susceptible to gen-
amycin, 80 (83.3%) strains were susceptible to ciproﬂoxacin, and
0 (62.5%) were susceptible to cloxacillin. All the 14 (100%) strains
f nonhemolytic Streptococcus were susceptible to cloxacillin, 13
92.8%) strains were susceptible to gentamycin and erythromycin,
ine (64.3%) strains were susceptible to ciproﬂoxacin, and seven
50.0%) were susceptible to cefaclor. It can be seen that the
uinolones and the aminoglycosides appear to be very effec-
ive against predominant pathogenic bacterial isolates, while
he emergence of resistance was recorded by K. pneumoniae
gainst each of methicillin, oxacillin, and erythromycin, respec-
ively. Antibacterial susceptibilities were signiﬁcantly dependent
n the type of pathogenic bacteria isolated and the type of antibi-
tics used.
.6.  Susceptibility status of pathogenic bacteria from Rukungiri
atientsAs  shown in Table 6, which depicts the summary of susceptibil-
ty results of pathogenic bacteria obtained from Rukungiri district,
ll ﬁve (100%) strains of E. coli were susceptible to gentamycin,
nd four (80.0%) strains were susceptible to ciproﬂoxacin. Out of
able 6
usceptibility pattern of 126 pathogenic bacterial isolates from Rukungiri district.
Organisms Antibiotics and number (%) positive
Met (10 g) Cip (5 g) Clox (5 g) Ox (1 g) 
E. coli (n = 5) 2 (20.0) 4 (80.0) 0 (0.0) 0 (0.0) 
K.  pneum (n = 83) 0 (0.0) 0 (0.0) 2 (2.4) 10 (12.0) 
S.  mutans (n = 34) 0 (0.0) 0 (0.0) 0 (0.0) 3 (8.8) 
B.  cereus (n = 18) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
NH  strept (n = 18) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
B.  subtilis (n = 2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
P  aerugin (n = 13) 0 (0.0) 8 (61.5) 0 (0.0) 2 (15.4) 
P.  mirab (n = 25) 0 (0.0) 18 (72.0) 0 (0.0) 3 (12.0) 
S.  aureus (n = 11) 4 (36.4) 7 (63.6) 0 (0.0) 5 (45.5) 
B.  catarrs (n = 9) 6 (66.7) 0 (0.0) 2 (22.2) 0 (0.0) 
ey: Met, Methicillin; Cip, Ciproﬂoxacin; Clox, Cloxacillin; Ox, Oxacillin; CCL, Cefaclor; Gen
treptococcus mutans; S. aureus, Staphylococcus aureus; P. aerugin, Pseudomonas aeruginosa;
.  subtilis, Bacillus subtilis; NH strept, non-hemolytic Streptococcus; B. catars, Brahmalella ca
ntibiotics when compared between different pathogenic bacteria (a) and within each balebsiella pneumoniae; E. coli, Escherichia coli; B. catars, Brahmalella catarrhalis. Using
pared between different pathogenic bacteria (a) and within each bacterium (b). (%)
the 83 K. pneumoniae isolated, 73 (86.7%) were susceptible to gen-
tamycin whereas other antibiotics used were poorly active against
K. pneumoniae. Out of the 34 strains of S. mutans isolated, 30
(88.2%) were susceptible to gentamycin and 20 (58.9%) were sus-
ceptible to erythromycin. All other antibiotics used were poorly
active against B. cereus. Out of the 18 nonhemolytic Streptococ-
cus isolates, 17 (94.4%) strains were susceptible to gentamycin.
Out of the 13 strains of P. aeruginosa isolates, 12 (92.3%) were
susceptible to gentamycin and eight (61.5%) were susceptible to
ciproﬂoxacin. Gentamycin, ciproﬂoxacin, and erythromycin were
among the most effective drugs used against the pathogenic bacte-
rial isolates. The pattern of observed antibacterial susceptibilities is
signiﬁcantly dependent on the type of pathogenic bacteria isolated
and the type of antibiotics used.
4. Discussion
Although studies on the pattern of microbial colonization of
the oral mucosa and antimicrobial susceptibility are abundant,
persistent oral lesions continue to intensify among patients with
HIV/AIDS receiving routine antimicrobial treatment in resource-
limited settings, emphasizing the need for an in-depth laboratory
investigation for microbial etiology. It appears that broadening the
treatment regimen for oral lesions to include pathogenic bacteria
etiology could help in the reduction of persistent oral lesions among
recipients of antimicrobial agents. Mapping the oral pathogenic
bacterial disease is important because the oral cavity is a known
potential source of systemic disease especially in the immuno-
compromised individuals [6,20]. The observation in this study, in
which females were simply more in number than males, is the
fact that gender poses a high risk in HIV distribution because
CCL (30 g) Gent (10 g) Amx  (25 g) Min  (5 g) Ery (5 g)
0 (0.0) 5 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
0 (0.0) 73 (86.7) 21 (25.3) 31 (37.3) 31 (37.3)
0 (0.0) 30 (88.2) 0 (0.0) 0 (0.0) 20 (58.9)
0 (0.0) 0 (0.0) 7 (38.9) 0 (0.0) 0 (0.0)
0 (0.0) 17 (94.4) 2 (11.1) 0 (0.0) 4 (22.2)
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
8 (61.5) 12 (92.3) 0 (0.0) 3 (23.1) 8 (61.5)
14 (56.0) 23 (92.3) 0 (0.0) 17 (68.0) 7 (28.0)
7 (63.6) 9 (81.8) 0 (0.0) 4 (36.4) 6 (54.5)
0 (0.0) 7 (77.8) 0 (0.0) 0 (0.0) 2 (22.2)
t, Gentamycin; Amx, Amoxycillin; Min, Minocycline; Ery, Erythromycin; S. mutans,
 K. pneum, Klebsiella pneumoniae; P. mirabilis, Proteus mirabilis; E. coli, Escherichia coli;
tarrhalis. Using RBD and FLSD, there was a signiﬁcant difference in the effect of the
cterium (b). (%) Percentage-sensitive.
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n sub-Saharan Africa males easily engage in risky multiple sex
ractice while females are denied the chance to negotiate for
ex [35]. However, we did not test for the statistical signiﬁcance
etween the observed higher females than males and the pattern
f bacteria distribution/sensitivity, among our randomly selected
opulation with HIV/AIDS in Uganda. This may  warrant further
tudy.
Oral pathogenic bacteria recovered from the mouth of patients
ith HIV/AIDS varied signiﬁcantly among participating districts,
ith the highest prevalence being 86.6% pathogenic bacterial iso-
ates from Masaka patients followed by 82.9% from Rukungiri
atients and 66.9% from Mbarara patients. The observed pattern
f variation is interestingly unique because Mbarara patients were
xpected to show a higher pathogenic bacterial prevalence com-
ared to patients from Masaka and Rukungiri districts in particular,
ecause most participants from Mbarara district came from remote
reas to reach villages where TASO provides monthly clinic-style
ervices to participants, while Rukungiri and Masaka provide daily
outine oral care at the clinic.
Oral care alone may  therefore not explain completely oral
athogenic bacterial prevalence because a higher oral care at
asaka and Rukungiri districts leads to a higher pathogenic bac-
erial prevalence compared to Mbarara, which had a lower rate
f oral care and a lower pathogenic bacterial prevalence. There-
ore, other underlying factors [19] such as microbial (pathogenic
acteria), immunological, and nonmicrobial factors (trauma, drugs,
ematinic deﬁciency, sodium-lauryl-sulfate-containing tooth-
aste, tobacco, and stress), not measured by this study, may  have
layed a role in this conﬂicting but interesting observation. The
icrobial population of the oral cavity remains relatively constant
n health; however, a variation in pathogenic bacterial popula-
ion seen in the studied districts may  suggest an emergence or a
rogress of oral disease [23].
The roles of pathogenic bacteria in oral infections are still highly
ebated compared to oral Candida. The observed signiﬁcant inﬂu-
nce of the study districts on the pattern of pathogenic bacteria
ecovered from the oral lesions of patients with HIV/AIDS may  be
xplained by the known idiosyncratic response of diverse popula-
ion to different diseases and drugs, thus depicting the distribution
f the two major ethnics (Bantus and Nile Hermites) made of ﬁve
ribes (Banyankole, Baganda, Bahororo, Bakiga, and Banyarwanda),
hich inhabit the study area [14–16,23]. The observed prevalence
f 31% S. mutans is strange because S. mutans is rarely associated
ith oral mucosal infections, and it may  be regarded as baseline
ata, as mainstream search does not seem to have a previous study.
e could not clarify whether the presence of S. mutans in the oral
ucosal lesions indicates an emergence of alliance between fungal
nd pathogenic bacterial agents in causing persistent oral lesions
f HIV/AIDS.
TASO offers relief and health package to its clients with HIV/AIDS
n both the clinics and the outreach centers. The available health
ackage at the time of this study excluded dental care but cov-
red health talks, routine clinical examination, administration
f co-trimoxazole, nystatin, and combined antiretroviral ther-
py (zidovudine, nevirapine, and stavudine), given in selection to
atients whose CD4 cells are <200. On the other hand, relief pack-
ges included food supplements and TV shows aimed at reducing
tigma and encouraging infected people to learn how to live with
IV virus.
All  the patients who received TASO health and relief package had
elatively poor oral hygiene, had no oral parasites, had low socioe-
onomy, used sucrose-rich antiretroviral therapy such as zidovu-
ine, used sugared milk contained in the TASO’s daily morning tea,
nd frequently took carbohydrates as staple food (locally called
matooke”). These factors are in line with oral conditions reported to
ncourage a high prevalence of S. mutans in oral infections, and theynational 12 (2015) 59–66
may have contributed to our observed 31% S. mutans prevalence in
oral lesions of patients with HIV/AIDS in this region [36–39].
TASO  record made available to us clearly indicated that a
monthly visit to >60% of participants in Mbarara region constituted
poor oral care because 4 weeks was  too long to ensure adherence.
Those who  missed medical attention due to an increasing number
of new cases had to wait until the next 4 weeks because they could
not afford to come to the regional clinics. Recommended supple-
mentation of the nystatin and co-trimoxazole routine drugs with
azoles, quinolones, and newer generation cephalosporins was sim-
ply impossible and not adhered to, due to the low socioeconomic
status of the patients already devastated by the HIV pandemic.
Although limited resources hindered us from getting more
details of microbial characteristics, standard and calibrated phe-
notypic microbiological methods were used to aseptically collect
and analyze clinical specimens for pathogenic bacterial identity.
It is therefore not clear if the method of microbial retrieval from
oral lesions played any role in the observed variations in the dis-
tribution of nonoral pathogenic bacteria as shown in Table 1. The
observed pattern of nonoral pathogenic bacteria colonizing the oral
lesions (Proteus species, S. aureus, P. aeruginosa, E. coli, diphtheroids,
and nonhemolytic Streptococcus species) is in line with the Brazil-
ian report [40]. The observed pattern of oral pathogenic bacterial
distribution may  also be due to the underlying diabetic condition
reported among the participating HIV-infected patients [41].
S.  aureus isolates are now more frequently isolated from the oral
cavity than anticipated, and they are the known potential sources
of systemic (including prosthetic joint and hip) infections [42,43].
Oral cavity Staphylococci are a potential source of prosthetic joint
infection. The mean 10.2% isolates in all the districts surveyed
are lower than the previous reports of 20% [42] and 2830% [43].
Although there were no data to conﬁrm if S. aureus was colonizing
or infecting the oral cavity, the role of S. aureus in several diseases
of the oral mucosa merits further investigation. The health risk of
enteric pathogenic bacteria recovered from the oral cavity may
be explained by the fact that nonpathogenic bacteria may  show
some pathogenicity through the trans-species transfer of genetic
material, a phenomenon already published elsewhere [44].
The  oro-facial soft and hard tissues of participants <20 years of
age were not destroyed to have suggested Noma or cancrum oris,
and there was  no osteomyelitis of the jaws to have explained the
isolation of up to 11% S. aureus from among the isolates [45,46].
We excluded Mycopathogenic bacteria screening due to poor facil-
ities and the complications involved in the clinical deﬁnition of skin
and oral infections of Mycopathogenic bacterial species [3,47]. There
was no classical chronic, nonhealing, deep, solitary oral ulceration
to have suggested oral syphilis [4]. There were no data to con-
ﬁrm salivary gland pathogenic bacterial infection (sialadenitis) of
8.3% of the patients with Xerostomia. Susceptibility, intermediate,
and resistance of isolates to used antibiotics were deﬁned using
standard guidelines [31,32].
Susceptibility in this study implied that isolates are inhibited by
the usually achievable concentration of antimicrobial agents when
the recommended dosage is used for the site of infection. An inter-
mediate included isolates with antimicrobial agent’s minimum
inhibitory concentrations (MICs) that approach usually attainable
blood and tissue levels and for which response rates may  be lower
than for susceptible isolates. It implies clinical efﬁcacy in body sites
where drugs are physiologically concentrated or when a higher
than normal dosage of drugs can be used. Resistance implies that
isolates are not inhibited by the usually achievable concentrations
of agents with normal dosage schedules, and/or that demonstrates
a zone diameter that falls in the range where speciﬁc microbial
resistance mechanisms are likely, and clinical efﬁcacy of the agents
against the isolates has not been reliably shown in treatment stud-
ies. In this study, both susceptible and intermediately susceptible
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ere recorded as susceptible so that we showed susceptibility pro-
le of isolates in Tables 4–6.
The result of penicillin resistance in oral pathogenic bacterial
nfections demonstrated using oxacillin, methicillin, cloxacillin,
enicillin G, and amoxicillin, as shown in Tables 2–4, was  in line
ith previous reports [48,33]. The addition of oxacillin in the
irby–Bauer modiﬁed disk diffusion experiment validates the use-
ulness of disk diffusion as a screening method for the detection
f pathogenic bacterial resistance to penicillin. Although penicillin
esistance by pathogenic bacteria is usually a consequence of -
actamase production, the mechanism of Streptococcal resistance
o penicillin centers on the alteration of the penicillin-binding pro-
eins found on the resistant Streptococci [48]. In all the districts,
s shown in Tables 4–6, gentamycin was the most effective drug
gainst all the oral pathogenic bacteria isolated, and this is in line
ith most of our earlier reports [48,49]. The observed suscepti-
ility of different pathogenic bacteria to different antibiotics was
igniﬁcantly inﬂuenced by pathogenic bacterial strains and district
f isolation.
An additional and interesting observation in this study is
hat some pathogenic bacterial isolates were relatively more
esistant to oral antibiotics and more sensitive to intravenous
rugs (Tables 4–6). In selection, some pathogenic bacteria also
howed relative resistance to amoxicillin and tetracyclines while
eing more sensitive to ciproﬂoxacin and cefaclor, respectively. In
ganda, there is no antibiotic prescription policy; thus, all antibi-
tics may  be purchased across the counter of local drug vendors or
harmacy shops by anyone. It is clear that allowing the locals to
urchase antibiotics without prescription may  expose them to the
isk of using sub-lethal dose to treat infections. This observation
ay have impacted on the pattern of sensitivity reported in this
tudy.
. Conclusion
This study has revealed a wide array of potentially pathogenic
acteria in the oral cavity of patients with HIV/AIDS, all of which
ose a real problem in the world of antimicrobial resistance, and
hey also clearly provide a higher risk of systemic infectious dis-
ases in these populations with HIV/AIDS. Oral pathogenic bacteria
opulation varied signiﬁcantly with participating districts depict-
ng the distribution of the two major ethnics (Bantus and Nile
ermites) made of ﬁve tribes (Banyankole, Baganda, Bahororo,
akiga, and Banyarwanda). TASO health and relief package encour-
ged a high prevalence of S. mutans in oral infections. Oral lesions
ielded a large proportion of nonoral pathogenic bacteria such
s P. mirabilis, nonhemolytic Streptococcus species, S. aureus, B.
atarrhalis, P. aeruginosa, K. pneumoniae, E. coli, S. pyogenes, Diph-
heroids, B. subtilis, and B. cereus. Some pathogenic bacterial isolates
ere relatively more resistant to oral antibiotics and more sensi-
ive to intravenous drugs. In selection, some pathogenic bacteria
howed relative resistance to penicillins and tetracyclines while
eing more sensitive to quinolones and cephalosporines, respec-
ively. Data on oral mucosal infections by other bacteria are
ncomplete in developed countries, and they are virtually nonex-
stent in low- and middle-income countries, indicating the need for
urther epidemiological studies.
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